Press releases
-
Korea Exchange grants preliminary approval on the 4th Subscriptions to the public offering will be ...2021. 02. 08 -
SK bioscience Collaborates with GSK on COVID-19 Vaccine Development and Initiate Phase I/II Trial ...2021. 02. 05 -
SK bioscience-GlaxoSmithKlein(GSK) co-promote five vaccines against Tdap, hepatitis A, meningococca...2021. 01. 06 -
- SK bioscience will apply for a certification for export from the Ministry of Food and Drug Safety(...2020. 12. 17 -
- SK bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) cooperate in develop...2020. 12. 10 -
SK bioscience will enter clinical trials of NBP2001 upon the IND approval from the Ministry of Foo...2020. 12. 02 -
- SK bioscience will submit an application for preliminary screening to the Korea Exchange (KRX) fo...2020. 11. 30 -
- The result of preclinical trial of a recombinant protein-based vaccine candidate, ‘NBP2001,’ is c...2020. 11. 25
-
- SK bioscience signs an agreement with Novavax to manufacture and supply COVID-19 vaccines global...2020. 08. 14 -
- NH Investment & Securities wereed as the lead underwriter and Korea Investment & Securit...2020. 07. 26